Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Complement activation in thrombotic microangiopathy.

Karpman, Diana LU orcid and Tati, Ramesh LU (2013) In Hämostaseologie 33(2). p.96-104
Abstract
The endothelium lining the vascular lumen is continuously exposed to complement from the circulation. When erroneously activated on host cells, complement may generate a deleterious effect on the vascular wall leading to endothelial injury, exposure of the subendothelial matrix and platelet activation.In this review the contribution of complement activation to formation and maintenance of the pathological lesion termed thrombotic microangiopathy (TMA) is discussed. TMA is defined by vessel wall thickening affecting mainly arterioles and capillaries, detachment of the endothelial cell from the basement membrane and intraluminal thrombosis resulting in occlusion of the vessel lumen. The TMA lesion occurs in haemolytic uraemic syndrome (HUS)... (More)
The endothelium lining the vascular lumen is continuously exposed to complement from the circulation. When erroneously activated on host cells, complement may generate a deleterious effect on the vascular wall leading to endothelial injury, exposure of the subendothelial matrix and platelet activation.In this review the contribution of complement activation to formation and maintenance of the pathological lesion termed thrombotic microangiopathy (TMA) is discussed. TMA is defined by vessel wall thickening affecting mainly arterioles and capillaries, detachment of the endothelial cell from the basement membrane and intraluminal thrombosis resulting in occlusion of the vessel lumen. The TMA lesion occurs in haemolytic uraemic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP). HUS is further sub-classified as associated with Shiga toxin-producing Escherichia coli (STEC-HUS) or with complement dysregulation (atypical HUS) as well as other less common forms. The contribution of dysregulated complement activation to endothelial injury and platelet aggregation is reviewed as well as specific complement involvement in the development of HUS and TTP. (Less)
Please use this url to cite or link to this publication:
author
and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Hämostaseologie
volume
33
issue
2
pages
96 - 104
publisher
Schattauer GmbH
external identifiers
  • wos:000320145200003
  • pmid:23411690
  • scopus:84881518113
  • pmid:23411690
ISSN
0720-9355
DOI
10.5482/HAMO-12-12-0025
language
English
LU publication?
yes
id
87b6b991-006e-4608-97c4-b216293ca9f0 (old id 3559762)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/23411690?dopt=Abstract
date added to LUP
2016-04-01 14:16:58
date last changed
2022-01-27 23:45:33
@article{87b6b991-006e-4608-97c4-b216293ca9f0,
  abstract     = {{The endothelium lining the vascular lumen is continuously exposed to complement from the circulation. When erroneously activated on host cells, complement may generate a deleterious effect on the vascular wall leading to endothelial injury, exposure of the subendothelial matrix and platelet activation.In this review the contribution of complement activation to formation and maintenance of the pathological lesion termed thrombotic microangiopathy (TMA) is discussed. TMA is defined by vessel wall thickening affecting mainly arterioles and capillaries, detachment of the endothelial cell from the basement membrane and intraluminal thrombosis resulting in occlusion of the vessel lumen. The TMA lesion occurs in haemolytic uraemic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP). HUS is further sub-classified as associated with Shiga toxin-producing Escherichia coli (STEC-HUS) or with complement dysregulation (atypical HUS) as well as other less common forms. The contribution of dysregulated complement activation to endothelial injury and platelet aggregation is reviewed as well as specific complement involvement in the development of HUS and TTP.}},
  author       = {{Karpman, Diana and Tati, Ramesh}},
  issn         = {{0720-9355}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{96--104}},
  publisher    = {{Schattauer GmbH}},
  series       = {{Hämostaseologie}},
  title        = {{Complement activation in thrombotic microangiopathy.}},
  url          = {{https://lup.lub.lu.se/search/files/3889813/3799614.pdf}},
  doi          = {{10.5482/HAMO-12-12-0025}},
  volume       = {{33}},
  year         = {{2013}},
}